Reprogramming of Virus-specific T Cells into Leukemia-reactive T Cells Using T Cell Receptor Gene Transfer

Journal of Experimental Medicine

Volumn 199, Issue 7, 2004, Pages 885-894

  Heemskerk, Mirjam H M ^a   Hoogeboom, Manja ^a   Hagedoorn, Renate ^a   Kester, Michel G D ^a   Willemze, Roel ^a   Falkenburg, J H Frederik ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gene transfer; Leukemia reactive; Minor histocompatibility antigen; T cell receptor; Virus specific T cells

Indexed keywords

HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLOIMMUNITY; ANTIGEN SPECIFICITY; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; FLOW CYTOMETRY; GENE TRANSFER; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CELL LINE, TUMOR; CYTOMEGALOVIRUS; CYTOTOXICITY, IMMUNOLOGIC; GENE TRANSFER TECHNIQUES; HUMANS; LEUKEMIA; MINOR HISTOCOMPATIBILITY ANTIGENS; NEOPLASM PROTEINS; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; VIRAL MATRIX PROTEINS;

EID: 1842631467     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031110     Document Type: Article

References (32)

1. Kolb, H.J., J. Mittermuller, C. Clemm, E. Holler, G. Ledderose, G. Brehm, M. Heim, and W. Wilmanns. 1990. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 76:2462-2465.
2. Collins, R.H., Jr., O. Shpilberg, W.R. Drobyski, D.L. Porter, S. Giralt, R. Champlin, S.A. Goodman, S.N. Wolff, W. Hu, C. Verfaillie, et al. 1997. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 15:433-444.
3. Porter, D.L., R.H. Collins, Jr., C. Hardy, N.A. Kernan, W.R. Drobyski, S. Giralt, M.E. Flowers, J. Casper, A. Leahey, P. Parker, et al. 2000. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood. 95:1214-1221.
4. Falkenburg, J.H., A.R. Wafelman, P. Joosten, W.M. Smit, C.A. van Bergen, R. Bongaerts, E. Lurvink, M. van der Hoorn, P. Kluck, J.E. Landegent, et al. 1999. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood. 94:1201-1208.
5. Dembic, Z., W. Haas, S. Weiss, J. McCubrey, H. Kiefer, H. von Boehmer, and M. Steinmetz. 1986. Transfer of specificity by murine alpha and beta T-cell receptor genes. Nature. 320:232-238.
6. Clay, T.M., M.C. Custer, J. Sachs, P. Hwu, S.A. Rosenberg, and M.I. Nishimura. 1999. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol. 163:507-513.
7. Fujio K. Y. Misaki, K. Setoguchi, S. Morita K. Kawahata, I. Kato, T. Nosaka, K. Yamamoto, and T. Kitamura. 2000. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex. J. Immunol. 165:528-532.
8. Calogero, A., G.A. Hospers, K.M. Kruse, P.I. Schrier, N.H. Mulder, E. Hooijberg, and L.F. de Leij. 2000. Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transfer. Anticancer Res. 20:1793-1799.
9. Heemskerk, M.H., R.A. de Paus, E.G. Lurvink, F. Koning, A. Mulder, R. Willemze, J.J. van Rood, and J.H. Falkenburg. 2001. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc. Natl. Acad. Sci. USA. 98:6806-6811.
10. Orentas, R.J., S.J. Roskopf, G.P. Nolan, and M.I. Nishimura. 2001. Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide. Clin. Immunol. 98:220-228.
11. Stanislawski, T., R.H. Voss, C. Lotz, E. Sadovnikova, R.A. Willemsen, J. Kuball, T. Ruppert, R.L. Bolhuis, C.J. Melief, C. Huber, et al. 2001. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat. Immunol. 2:962-970.
12. Rubinstein, M.P., A.N. Kadima, M.L. Salem, C.L. Nguyen, W.E. Gillanders, M.I. Nishimura, and D.J. Cole. 2003. Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity. J. Immunol. 170:1209-1217.
13. Schaft, N., R.A. Willemsen, J. De Vries, B. Lankiewicz, B.W. Essers, J.W. Gratama, C.G. Figdor R.L. Bolhuis, R. Debets, and G.J. Adema. 2003. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes. J. Immunol. 170:2186-2194.
14. Kessels, H.W., M.C. Wolkers, M.D. van den Boom, M.A. van der Valk, and T.N. Schumacher. 2001. Immunotherapy through TCR gene transfer. Nat. Immunol. 2:957-961.
15. Falkenburg, J.H., W.M. Smit, and R. Willemze. 1997. Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunol. Rev. 157:223-230.
16. de Bueger, M., A. Bakker, J.J. van Rood, F. Van der Woude, and E. Goulmy. 1992. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J. Immunol. 149:1788-1794.
17. Marijt, W.A., M.H. Heemskerk, F.M. Kloosterboer, E. Goulmy, M.G. Kester, M.A. van der Hoorn, S.A. van Luxemburg-Heys, M. Hoogeboom, T. Mutis, J.W. Drijfhout, et al. 2003. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc. Natl. Acad. Sci. USA. 100:2742-2747.
18. van Els, C.A., J. D'Amaro, J. Pool, E. Blokland, A. Bakker, P.J. van Elsen, J.J. van Rood, and E. Goulmy. 1992. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics. 35:161-165.
19. Munz, C., R. Obst, W. Osen, S. Stevanovic, and H.G. Rammensee. 1999. Alloreactivity as a source of high avidity peptide-specific human CTL. J. Immunol. 162:25-34.
20. Amrolia, P.J., S.D. Reid, L. Gao, B. Schultheis, G. Dotti, M.K. Brenner, J.V. Melo, J.M. Goldman, and H.J. Stauss. 2003. Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity. Blood. 101:1007-1014.
21. Gao, L., I. Bellantuono, A. Elsasser, S.B. Marley, M.Y. Gordon, J.M. Goldman, and H.J. Stauss. 2000. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood. 95:2198-2203.
22. Sadovnikova, E., L.A. Jopling, K.S. Soo, and H.J. Stauss. 1998. Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules. Eur. J. Immunol. 28:193-200.
23. Mutis, T., E. Blokland, M. Kester, E. Schrama, and E. Goulmy. 2002. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation. Blood. 100:547-552.
24. Mutis, T., G. Gillespie, E. Schrama, J.H. Falkenburg, P. Moss, and E. Goulmy. 1999. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat. Med. 5:839-842.
25. Arden, B., S.P. Clark, D. Kabelitz, and T.W. Mak. 1995. Human T-cell receptor variable gene segment families. Immunogenetics. 42:455-500.
26. Kinsella, T.M., and G.P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.
27. Heemskerk, M.H., B. Blom, G. Nolan, A.P. Stegmann, A.Q. Bakker, K. Weijer, P.C. Res, and H. Spits. 1997. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186:1597-1602.
28. Ruggieri, L., A. Aiuti, M. Salomoni, E. Zappone, G. Ferrari, and C. Bordignon. 1997. Cell-surface marking of CD (34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum. Gene Ther. 8:1611-1623.
29. Hanenberg, H., X.L. Xiao, D. Dilloo, K. Hashino, I. Kato, and D.A. Williams. 1996. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Med. 2:876-882.
30. Burrows, S.R., N. Kienzle, A. Winterhalter, M. Bharadwaj, J.D. Altman, and A. Brooks. 2000. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J. Immunol. 165:6229-6234.
31. Smit, W.M., M. Rijnbeek, C.A. van Bergen, W.E. Fibbe, R. Willemze, and J.H. Falkenburg. 1998. T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc. Natl. Acad. Sci. USA. 95:10152-10157.
32. van der Hoorn, M.A., S.A. van Luxemburg-Heijs, C.A. van Bergen, R. Bongaerts, R. Willemze, and J.H. Falkenburg. 2003. The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia. Methods. 31:113-119.